Safety of abatacept or infliximab in RA patients with an inadequate response to MTX: Results from a 1-year double-blind randomized clinical trial

Category Primary study
JournalScandinavian journal of rheumatology
Year 2008

This article is included in 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
  • ATTEST [Abatacept or infliximab vs placebo, a Trial for Tolerability, Efficacy and Safety in Treating rheumatoid arthritis] (7 documents)
This article is part of the following matrixes of evidence:
Loading references information
This article has no abstract
Epistemonikos ID: 7d0a9449604cf9c980b7c442a6fffbfa71f04018
First added on: Oct 21, 2017